Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
The AAPS Journal|July 14, 2010
A novel ultrasensitive hybridization-based ELISA method for 2-methoxyphosphorothiolate microRNAs and its in vitro and in vivo applicationKenneth K Chan, Zhongfa Liu, Zhiliang Xie, et al.
International Journal of Cancer|April 20, 2004
Carotenoids/vitamin C and smoking-related bladder cancerJ Esteban Castelao, Jian-Min Yuan, Manuela Gago-Dominguez, et al.
Journal of Clinical Pharmacology|January 25, 2007
Population pharmacokinetics of humanized monoclonal antibody HuCC49deltaCH2 and murine antibody CC49 in colorectal cancer patientsLanyan Fang, Nicholas H G Holford, George Hinkle, et al.
Plos One|March 5, 2013
Curcumin down-regulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemiaJianhua Yu, Yong Peng, Lai-Chu Wu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 1, 2009
Delivery of antisense oligodeoxyribonucleotide lipopolyplex nanoparticles assembled by microfluidic hydrodynamic focusingChee Guan Koh, Xulang Zhang, Shujun Liu, et al.
Molecular Pharmaceutics|April 15, 2015
CD33-Targeted Lipid Nanoparticles (aCD33LNs) for Therapeutic Delivery of GTI-2040 to Acute Myelogenous LeukemiaHong Li, Songlin Xu, Jishan Quan, et al.
Molecular Pharmaceutics|October 27, 2009
Targeted delivery of antisense oligodeoxynucleotide by transferrin conjugated pH-sensitive lipopolyplex nanoparticles: a novel oligonucleotide-based therapeutic strategy in acute myeloid leukemiaYan Jin, Shujun Liu, Bo Yu, et al.
The AAPS Journal|March 5, 2016
Preclinical Pharmacokinetics Study of R- and S-Enantiomers of the Histone Deacetylase Inhibitor, AR-42 (NSC 731438), in RodentsHao Cheng, Zhiliang Xie, William P Jones, et al.
The AAPS Journal|April 19, 2011
Characterization of silvestrol pharmacokinetics in mice using liquid chromatography-tandem mass spectrometryU V R Vijaya Saradhi, Sneha V Gupta, Ming Chiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasmsVictor Sandor, Susan Bakke, Robert W Robey, et al.
Pageof 10